PALO ALTO, Calif.--Maker of genomics database products, Incyte Pharmaceuticals extended for three more years its collaboration with Pfizer and expanded the scope of its original 1994 agreement to allow Pfizer access to a proprietary Incyte database of full-length genes and a DNA clone set. Pfizer will have continued access to the gene sequence and expression database it has contracted since 1994. Financial terms of the agreement were not disclosed.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.